Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Early diagnosis and treatment of alopecia areata in children is crucial to prevent severe progression.

Upadacitinib improved multiple immune-related conditions in one patient.

Higher inflammation markers are linked to more severe alopecia areata.

Higher IL-17A levels indicate more severe alopecia areata.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

People with severe and long-lasting alopecia areata often have low vitamin D levels, and treatments with vitamin D-like substances might help.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Higher IL-21 levels may help predict alopecia areata activity.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Alopecia areata treatment varies, with no optimal method established yet.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.